Considering that heterodimers composed of CD49f and CD29 mainly mediated the laminin‐binding properties of Ph‐positive ALL cell lines, downregulation of CD49f by imatinib treatment may disrupt the laminin adhesion of these cell lines. The gene discussed is LAMB2; the disease is acute lymphoblastic leukemia.